These guidelines are the result of extensive research and are published by leading consortia and professional societies dedicated to incorporating genetic insights into clinical care. Prominent among these are the Clinical Pharmacogenetics Implementation Consortium (CPIC), the Royal Dutch Association for the Advancement of Pharmacy – Dutch Pharmacogenetics Working Group (DPWG), the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), and the French National Network of Pharmacogenetics (RNPGx). These esteemed organizations are at the forefront of developing and revising guidelines that integrate pharmacogenetics into medication prescribing practices, ensuring patients receive the most personalized and effective treatments possible.
Our PGX testing is aligned with these official guidelines to ensure the highest standard of precision in medication management. By examining the individual genetic makeup, we provide insights that help tailor the right medication at the right dose, optimizing efficacy and reducing the risk of adverse effects.
Explore our curated list of medications that benefit from pharmacogenomic insights:
The medications listed are organized by therapeutic use or drug class for easy navigation. The genes we test for each medication are indicated in parentheses. Our testing panels cover the most prevalent gene variants. For detailed variant information, please reach out to us directly.
Copyright © 2023 DNAPLUS